Pharma News

The coronavirus' structure is an all-too-familiar image, with its densely packed surface receptors resembling a thorny crown.

Pfizer bows out of China's ever-crowded biosimilar market—for now—and sells a biologics facility to CDMO giant WuXi Biologics.

Two months after GlaxoSmithKline and Merck KGaA’s oncology asset bintrafusp alfa failed to beat out King Keytruda in certain lung cancers, it has followed up with another disappointment.

The study found that the percentage of adults 65 and older who were prescribed a fall- risk-increasing drug climbed to 94% in 2017, a significant leap from 57% in 1999.

A new concept of on-demand drug delivery system has emerged in which the drugs are automatically released from in vivo medical devices simply by shining light on the skin.

Long-term data from Janssen’s Phase III DISCOVER-2a trial show that TREMFYA® (guselkumab), a selective IL-23 inhibitor, lead to skin clearance and joint symptom relief for up to two years i...

Antimicrobial resistance is a global problem.

(Reuters) - Moderna Inc said on Monday it had dosed the first participant in an early-stage study of a new COVID-19 vaccine candidate that could potentially be stored and shipped in refrigerat...

Researchers examined data collected in China's Yunnan province between May 2019 and November 2020.

London (CNN)Spain, Germany, France and Italy have become the latest European countries to temporarily halt the rollout of the Oxford-AstraZeneca Covid-19 vaccine over a small number of blood c...

Swiss pharma giant Roche said Monday it would pay $1.

Eli Lilly & Co.